Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest chemotherapy Stories

2013-10-28 08:28:31

November 1, 2013 at 2:00 PM EDT PRINCETON, N.J., Oct. 28, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that Christopher J. Schaber, PhD, President and Chief Executive Officer, Oreola Donini, PhD, Vice President of Preclinical Research and Development,...

2013-10-24 08:34:57

SAN FRANCISCO and BUFFALO, N.Y., Oct. 24, 2013 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) and Roswell Park Cancer Institute (RPCI) announced today that the first patients have been dosed in a phase II investigator-sponsored study of etirinotecan pegol in patients with relapsed or refractory Small-Cell Lung Cancer (SCLC). The study is being conducted at Roswell Park under the direction of Alex Adjei, M.D., Ph.D., F.A.C.P., Senior Vice President for Clinical Research and Chair of the...

2013-10-24 08:33:48

FREDERICK, Md., Oct. 24, 2013 /PRNewswire/ -- Vaccinogen, Inc., (OTC.QB: VGEN) a cancer vaccine company, today announced that noted pediatric neurosurgeon Benjamin S. Carson, M.D. and prominent oncologist Jan B. Vermorken, M.D., Ph.D. have joined the company's medical advisory board. Drs. Carson and Vermorken complement Vaccinogen's existing medical advisory board members: John S. Macdonald, M.D., a highly recognized colorectal surgeon; Herbert C. Hoover, Jr., M.D., a leader in the...

2013-10-22 16:24:35

Nine Innovative Researchers Receive First-Time Grant WHITE PLAINS, N.Y., Oct. 22, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today is pleased to announce the researchers who will receive The New Idea Award--a grant program designed to identify novel research strategies with high potential for significant impact on the future of blood cancer treatments. Specifically, this program supports academic researchers with innovative ideas for substantially different...

2013-10-22 12:36:18

Researchers at the University of California, San Diego School of Medicine have discovered a way to effectively deliver staurosporine (STS), a powerful anti-cancer compound that has vexed researchers for more than 30 years due to its instability in the blood and toxic nature in both healthy and cancerous cells. For the first time, the new method safely delivered STS to mouse tumors, suppressing them with no apparent side effects. The results were published online, October 20, in the...

2013-10-21 08:29:07

VAL-083 therapeutic activity seen in glioblastoma, chronic myelogenous leukemia and non-small cell lung cancer VANCOUVER, British Columbia and MENLO PARK, Calif., Oct. 21, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting. The data presented today, along with historical research by the U.S....

2013-10-20 23:03:15

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new technique developed by scientists that allows cancer treatments to gain access to the brain. New York, NY (PRWEB) October 20, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new way for cancer treatments to access the brain, increasing their effectiveness. According to an October 17, 2013 article published by The...

2013-10-16 23:29:24

MarketResearchReports.Biz announces addition of new report “Global Chemotherapy Induced Nausea and Vomiting Clinical Trials 2013” to its database. Visit: http://www.marketresearchreports.biz/analysis-details/chemotherapy-induced-nausea-and-vomiting-global-clinical-trials-review-h2-2013 Albany, NY (PRWEB) October 16, 2013 Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013 GlobalData's clinical trial report, Chemotherapy Induced Nausea and Vomiting...

2013-10-16 08:28:45

- Co-investors include Hatteras Venture Partners and Mountain Group Capital CHAPEL HILL, N.C., Oct. 16, 2013 /PRNewswire/ -- G1 Therapeutics, Inc. today announced that it has raised a Series A financing of $12.5M that will enable the advancement of its lead clinical candidate through the filing of an Investigational New Drug application (IND) and initial clinical testing. The financing was led by MedImmune Ventures. Co-investors include Hatteras Venture Partners and Mountain Group...

2013-10-15 04:21:08

CAMBRIDGE, England, October 15, 2013 /PRNewswire/ -- Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients. The study showed that APD515 significantly reduced the symptoms of dry mouth (the primary endpoint) compared to placebo. APD515 is an optimised oromucosal (liquid) formulation of a currently...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »